McKesson Completes Apollo Investment in MMS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 02 2026
0mins
McKesson (MCK) announced the successful completion of the previously announced minority ownership interest investment from funds managed by affiliates of Apollo (APO) in McKesson's Medical-Surgical Solutions, MMS, business on June 1, 2026. This transaction represents a key milestone in McKesson's intention to separate MMS into an independent, publicly traded company, and positions the business for long-term growth. Apollo Funds invested $1.25B in convertible preferred equity of MMS to acquire an approximately 13% interest in MMS. The transaction values MMS at approximately $13B total enterprise valuation. McKesson retains operating control and majority ownership of MMS and will consolidate the results for financial reporting.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MCK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MCK
Wall Street analysts forecast MCK stock price to rise
14 Analyst Rating
12 Buy
2 Hold
0 Sell
Strong Buy
Current: 779.800
Low
880.00
Averages
942.83
High
1000.00
Current: 779.800
Low
880.00
Averages
942.83
High
1000.00
About MCK
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cardinal Health Continues Growth with Stock Price Surge
- Outstanding Stock Performance: Cardinal Health achieved a remarkable 74% stock price increase in 2025, followed by a 7.9% rise year-to-date in 2026, reflecting sustained investor confidence in its growth strategy, significantly outperforming peers McKesson and Cencora.
- Enhanced Profitability: In its fiscal Q3 2026 earnings report, the company reported a 35% EPS growth and raised its earnings guidance again, underscoring management's confidence in sustained operational momentum despite macro uncertainties and pricing pressures.
- Strong Specialty Pharmaceutical Business: Cardinal Health's Pharmaceutical and Specialty Solutions segment saw an 11% revenue increase to $56.1 billion and an 18% profit rise in Q3, with expectations for specialty sales to exceed $50 billion in fiscal 2026, indicating robust growth potential in the market.
- Rapid Expansion of New Businesses: The company's
See More
IYK ETF 52-Week Price Range Analysis
- Price Fluctuation Analysis: The IYK ETF has a 52-week low of $65.21 and a high of $77.70, with the last trade at $73.34, indicating stability within its trading range that may attract investor interest.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average provides valuable insights for investors, aiding in market trend assessment and potential buying opportunities.
- ETF Unit Trading Mechanism: ETFs trade similarly to stocks, where investors buy and sell 'units' that can be created or destroyed based on demand, impacting liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in ETF shares outstanding highlights significant inflows (new units created) or outflows (old units destroyed), which can affect the underlying stocks held by the ETF and influence overall market dynamics.
See More
Market Dynamics and Investment Strategy Analysis
- Market Opening Outlook: Following President Trump's remarks about Iran's delay in peace negotiations, stocks are expected to open lower, with rising oil prices; although the May consumer price index met expectations, the market's anticipation of a Fed interest rate hike indicates investor caution regarding future economic conditions.
- SpaceX IPO Activity: As investors liquidate stock positions to buy into the SpaceX IPO, this trend is expected to intensify ahead of Friday's trading start, with the need for rebalancing in the Nasdaq 100 index making large-cap companies significant contributors, reflecting strong market interest in emerging tech firms.
- Enterprise Model Launch: Anthropic unveiled its high-powered enterprise model, Claude Fable 5, based on Mythos, promising a measured release approach due to its effectiveness in identifying security flaws, showcasing the company's innovative potential in the AI sector.
- Analyst Rating Changes: Evercore ISI upgraded Entergy from hold to buy, raising the price target from $115 to $121, as analysts expressed confidence in the management's ability to attract significant demand, reflecting an optimistic outlook for the electric power industry.
See More
McKesson Reports Strong Q4 2026 Earnings with Strategic Growth Plans
- Strong Financial Performance: McKesson reported an adjusted earnings per diluted share of $11.69 for Q4 2026, with consolidated revenues increasing by 6% to $96.3 billion and gross profit rising by 14% to $3.9 billion, indicating robust market performance and profitability.
- Shareholder Return Initiatives: The company returned $5.1 billion to shareholders through share repurchases in fiscal 2026 and anticipates free cash flow to remain between $4.5 billion and $4.9 billion in fiscal 2027, reflecting management's confidence in future cash generation and commitment to shareholders.
- Separation Progress: McKesson is advancing its plan to spin off its Medical-Surgical Solutions segment into an independent entity, having secured a $1.25 billion strategic investment from Apollo, which is expected to unlock shareholder value and enhance strategic clarity.
- Future Growth Outlook: The company projects adjusted earnings per diluted share in the range of $43.80 to $44.60 for fiscal 2027, with revenue growth expectations of 14.5% to 18.5% in the oncology and multispecialty segment, showcasing a positive outlook on new market opportunities.
See More
Market Dynamics: Oil Prices and Tech Stocks Fluctuate
- Oil Price Recovery: West Texas Intermediate crude oil prices rebounded above $97 per barrel after a morning dip, reflecting cautious optimism about future demand, which could impact related energy stocks' performance.
- Divergent Tech Stock Performance: As AI-related stocks pull back, cybersecurity software stocks like CrowdStrike and Palo Alto Networks surged, crossing $500 and $190 respectively for the first time, indicating increased market confidence in their business models and potentially attracting more investor interest.
- Boeing Stock Rise: Boeing's shares rose as CEO Kelly Ortberg is set to accompany President Trump on his trip to China, with the market anticipating a major order of up to 500 planes, although skepticism remains regarding the order's realization.
- Employment Data Expectations: Economists forecast a 65,000 increase in April's nonfarm payrolls with the unemployment rate steady at 4.3%, while average hourly earnings are expected to rise by 3.8%, providing crucial economic health indicators that could influence investor confidence.
See More
S&P 500 Continues Record Run Fueled by AI Spending Boom
- Earnings Season Begins: Eaton is set to report earnings on Tuesday, with expectations of a roughly 200% year-over-year increase in data center orders within its Electrical Americas segment, indicating that AI buildout is driving order growth and enhancing the company's competitiveness in the data center market.
- DuPont Performance Focus: DuPont will also report on Tuesday, with its Healthcare & Water Technologies segment expected to achieve mid-single-digit organic growth, reflecting the company's strategic direction post-electronics spin-off, and investors will closely watch for commentary on changes in customer behavior.
- Arm Holdings First Earnings Call: Arm will report earnings on Wednesday, focusing on its newly launched AI central processing unit (CPU), which, although not yet on the market, is expected to drive future cloud revenue growth, with investors keen on the health of its smartphone royalty stream.
- Corning Investor Day: Corning will hold an investor day on Wednesday, expected to update its
See More
Cardinal Health Continues Growth with Stock Price Surge
- Outstanding Stock Performance: Cardinal Health achieved a remarkable 74% stock price increase in 2025, followed by a 7.9% rise year-to-date in 2026, reflecting sustained investor confidence in its growth strategy, significantly outperforming peers McKesson and Cencora.
- Enhanced Profitability: In its fiscal Q3 2026 earnings report, the company reported a 35% EPS growth and raised its earnings guidance again, underscoring management's confidence in sustained operational momentum despite macro uncertainties and pricing pressures.
- Strong Specialty Pharmaceutical Business: Cardinal Health's Pharmaceutical and Specialty Solutions segment saw an 11% revenue increase to $56.1 billion and an 18% profit rise in Q3, with expectations for specialty sales to exceed $50 billion in fiscal 2026, indicating robust growth potential in the market.
- Rapid Expansion of New Businesses: The company's
See More
IYK ETF 52-Week Price Range Analysis
- Price Fluctuation Analysis: The IYK ETF has a 52-week low of $65.21 and a high of $77.70, with the last trade at $73.34, indicating stability within its trading range that may attract investor interest.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average provides valuable insights for investors, aiding in market trend assessment and potential buying opportunities.
- ETF Unit Trading Mechanism: ETFs trade similarly to stocks, where investors buy and sell 'units' that can be created or destroyed based on demand, impacting liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in ETF shares outstanding highlights significant inflows (new units created) or outflows (old units destroyed), which can affect the underlying stocks held by the ETF and influence overall market dynamics.
See More
Market Dynamics and Investment Strategy Analysis
- Market Opening Outlook: Following President Trump's remarks about Iran's delay in peace negotiations, stocks are expected to open lower, with rising oil prices; although the May consumer price index met expectations, the market's anticipation of a Fed interest rate hike indicates investor caution regarding future economic conditions.
- SpaceX IPO Activity: As investors liquidate stock positions to buy into the SpaceX IPO, this trend is expected to intensify ahead of Friday's trading start, with the need for rebalancing in the Nasdaq 100 index making large-cap companies significant contributors, reflecting strong market interest in emerging tech firms.
- Enterprise Model Launch: Anthropic unveiled its high-powered enterprise model, Claude Fable 5, based on Mythos, promising a measured release approach due to its effectiveness in identifying security flaws, showcasing the company's innovative potential in the AI sector.
- Analyst Rating Changes: Evercore ISI upgraded Entergy from hold to buy, raising the price target from $115 to $121, as analysts expressed confidence in the management's ability to attract significant demand, reflecting an optimistic outlook for the electric power industry.
See More
McKesson Reports Strong Q4 2026 Earnings with Strategic Growth Plans
- Strong Financial Performance: McKesson reported an adjusted earnings per diluted share of $11.69 for Q4 2026, with consolidated revenues increasing by 6% to $96.3 billion and gross profit rising by 14% to $3.9 billion, indicating robust market performance and profitability.
- Shareholder Return Initiatives: The company returned $5.1 billion to shareholders through share repurchases in fiscal 2026 and anticipates free cash flow to remain between $4.5 billion and $4.9 billion in fiscal 2027, reflecting management's confidence in future cash generation and commitment to shareholders.
- Separation Progress: McKesson is advancing its plan to spin off its Medical-Surgical Solutions segment into an independent entity, having secured a $1.25 billion strategic investment from Apollo, which is expected to unlock shareholder value and enhance strategic clarity.
- Future Growth Outlook: The company projects adjusted earnings per diluted share in the range of $43.80 to $44.60 for fiscal 2027, with revenue growth expectations of 14.5% to 18.5% in the oncology and multispecialty segment, showcasing a positive outlook on new market opportunities.
See More
Market Dynamics: Oil Prices and Tech Stocks Fluctuate
- Oil Price Recovery: West Texas Intermediate crude oil prices rebounded above $97 per barrel after a morning dip, reflecting cautious optimism about future demand, which could impact related energy stocks' performance.
- Divergent Tech Stock Performance: As AI-related stocks pull back, cybersecurity software stocks like CrowdStrike and Palo Alto Networks surged, crossing $500 and $190 respectively for the first time, indicating increased market confidence in their business models and potentially attracting more investor interest.
- Boeing Stock Rise: Boeing's shares rose as CEO Kelly Ortberg is set to accompany President Trump on his trip to China, with the market anticipating a major order of up to 500 planes, although skepticism remains regarding the order's realization.
- Employment Data Expectations: Economists forecast a 65,000 increase in April's nonfarm payrolls with the unemployment rate steady at 4.3%, while average hourly earnings are expected to rise by 3.8%, providing crucial economic health indicators that could influence investor confidence.
See More
S&P 500 Continues Record Run Fueled by AI Spending Boom
- Earnings Season Begins: Eaton is set to report earnings on Tuesday, with expectations of a roughly 200% year-over-year increase in data center orders within its Electrical Americas segment, indicating that AI buildout is driving order growth and enhancing the company's competitiveness in the data center market.
- DuPont Performance Focus: DuPont will also report on Tuesday, with its Healthcare & Water Technologies segment expected to achieve mid-single-digit organic growth, reflecting the company's strategic direction post-electronics spin-off, and investors will closely watch for commentary on changes in customer behavior.
- Arm Holdings First Earnings Call: Arm will report earnings on Wednesday, focusing on its newly launched AI central processing unit (CPU), which, although not yet on the market, is expected to drive future cloud revenue growth, with investors keen on the health of its smartphone royalty stream.
- Corning Investor Day: Corning will hold an investor day on Wednesday, expected to update its
See More
